• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童同时或序贯接种 2009 年 H1N1 疫苗和 2009-2010 年季节性三价流感疫苗后的安全性和免疫应答。

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

机构信息

Division of Infectious Diseases, Allergy and Immunology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.

出版信息

J Infect Dis. 2012 Sep 15;206(6):828-37. doi: 10.1093/infdis/jis445. Epub 2012 Jul 16.

DOI:10.1093/infdis/jis445
PMID:22802432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3501155/
Abstract

BACKGROUND

Administering 2 separate vaccines for seasonal and pandemic influenza was necessary in 2009. Therefore, we conducted a randomized trial of monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine) and seasonal trivalent inactivated influenza vaccine (TIV; split virion) given sequentially or concurrently in previously vaccinated children.

METHODS

Children randomized to 4 study groups and stratified by age received 1 dose of seasonal TIV and 2 doses of 2009 H1N1 vaccine in 1 of 4 combinations. Injections were given at 21-day intervals and serum samples for hemagglutination inhibition antibody responses were obtained prior to and 21 days after each vaccination. Reactogenicity and adverse events were monitored.

RESULTS

All combinations of vaccines were safe in the 531 children enrolled. Generally, 1 dose of 2009 H1N1 vaccine and 1 dose of TIV, regardless of sequence or concurrency of administration, was immunogenic in children ≥ 10 years of age; children <10 years of age required 2 doses of 2009 H1N1 vaccine.

CONCLUSIONS

Vaccines were generally well tolerated. The immune responses to 2009 H1N1 vaccine were adequate regardless of the sequence of vaccination in all age groups but the sequence affected titers to TIV antigens. Two doses of 2009 H1N1 vaccine were required to achieve a protective immune response in children <10 years of age.

CLINICAL TRIALS REGISTRATION

NCT00943202.

摘要

背景

2009 年,需要同时接种两种疫苗来预防季节性流感和大流行性流感。因此,我们进行了一项随机试验,比较了单价 2009 年 H1N1 流感疫苗(2009 年 H1N1 疫苗)和季节性三价灭活流感疫苗(裂解病毒)先后序贯或同时接种在已接种疫苗儿童中的效果。

方法

随机分为 4 组的儿童按年龄分层,接受 1 剂季节性 TIV 和 2 剂 2009 年 H1N1 疫苗,4 种组合中的 1 种。间隔 21 天给予注射,在每次接种前和接种后 21 天采集血清样本进行血凝抑制抗体反应。监测不良反应和不良事件。

结果

531 名入组儿童的所有疫苗组合均安全。一般来说,1 剂 2009 年 H1N1 疫苗和 1 剂 TIV,无论给药顺序如何,均可在年龄≥10 岁的儿童中产生免疫原性;年龄<10 岁的儿童需要接种 2 剂 2009 年 H1N1 疫苗。

结论

疫苗通常具有良好的耐受性。在所有年龄组中,无论接种顺序如何,2009 年 H1N1 疫苗的免疫应答均足够,但接种顺序会影响 TIV 抗原的滴度。10 岁以下儿童需要接种 2 剂 2009 年 H1N1 疫苗才能产生保护性免疫应答。

临床试验注册

NCT00943202。

相似文献

1
Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.儿童同时或序贯接种 2009 年 H1N1 疫苗和 2009-2010 年季节性三价流感疫苗后的安全性和免疫应答。
J Infect Dis. 2012 Sep 15;206(6):828-37. doi: 10.1093/infdis/jis445. Epub 2012 Jul 16.
2
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?6至23个月大儿童的流感疫苗免疫原性:启动免疫是否需要相同抗原?
Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198.
3
Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.2009年甲型H1N1流感大流行疫苗与2009 - 2010年季节性三价流感疫苗同时接种或序贯接种的成人II期试验。
Vaccine. 2015 Jan 1;33(1):163-73. doi: 10.1016/j.vaccine.2014.10.083. Epub 2014 Nov 11.
4
Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age.哺乳动物细胞培养流感疫苗在 3 至 17 岁健康儿童和青少年中的免疫原性、安全性和反应原性。
Pediatr Infect Dis J. 2012 May;31(5):494-500. doi: 10.1097/INF.0b013e31824bb179.
5
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.一项候选灭活四价流感疫苗与三价流感疫苗在 3-17 岁儿童中的随机对照试验。
J Infect Dis. 2013 Jun 15;207(12):1878-87. doi: 10.1093/infdis/jit091. Epub 2013 Mar 7.
6
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.对部分免疫的幼儿接种三价灭活流感疫苗。
Pediatrics. 2006 Sep;118(3):e579-85. doi: 10.1542/peds.2006-0201.
7
Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.使用MF59佐剂或无佐剂季节性流感疫苗进行初免的儿童流感疫苗接种。
Hum Vaccin Immunother. 2015;11(8):2102-12. doi: 10.1080/21645515.2015.1044167.
8
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.一项针对两种大流行流感疫苗在儿童中进行的随机、头对头、多中心、开放性研究的 1 年随访研究。
Health Technol Assess. 2011 Dec;15(45):v-vi, xi-xiii, 1-128. doi: 10.3310/hta15450.
9
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.在 18 岁及以上成年人中,一种四价流感疫苗候选株与三价流感疫苗的免疫原性、反应原性和安全性:一项 III 期、随机试验。
BMC Infect Dis. 2013 Jul 24;13:343. doi: 10.1186/1471-2334-13-343.
10
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.接种含佐剂或全病毒大流行疫苗 1 年后 H1N1 抗体持久性,以及随后接种季节性流感疫苗的免疫原性和反应原性:一项多中心后续研究。
Clin Infect Dis. 2012 Mar 1;54(5):661-9. doi: 10.1093/cid/cir905. Epub 2012 Jan 19.

引用本文的文献

1
Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011-2019.2011-2019 年香港<9 岁儿童部分和全剂量流感疫苗接种的效果。
J Infect Dis. 2019 Oct 8;220(10):1568-1576. doi: 10.1093/infdis/jiz361.
2
Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.2009年甲型H1N1流感大流行疫苗与2009 - 2010年季节性三价流感疫苗同时接种或序贯接种的成人II期试验。
Vaccine. 2015 Jan 1;33(1):163-73. doi: 10.1016/j.vaccine.2014.10.083. Epub 2014 Nov 11.
3
Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.儿童对甲型H1N1流感大流行疫苗(2009)的临床及免疫反应
Pediatr Infect Dis J. 2014 Aug;33(8):865-71. doi: 10.1097/INF.0000000000000329.
4
Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.标准三价流感病毒蛋白疫苗接种不能在猕猴中引发抗体依赖的细胞细胞毒性。
J Virol. 2013 Dec;87(24):13706-18. doi: 10.1128/JVI.01666-13. Epub 2013 Oct 9.
5
Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines.针对灭活或减毒流感病毒疫苗产生反应的抗体形成细胞的差异定位和功能。
Int Immunol. 2013 Mar;25(3):183-95. doi: 10.1093/intimm/dxs107. Epub 2012 Nov 8.

本文引用的文献

1
Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.北京地区 2009 年 H1N1 流感疫苗的安全性和有效性
N Engl J Med. 2010 Dec 16;363(25):2416-23. doi: 10.1056/NEJMoa1006736.
2
Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials.在两项随机对照试验中,向儿童和成人接种活的、减毒的单价 2009 年 H1N1 流感疫苗的安全性和免疫原性。
PLoS One. 2010 Oct 29;5(10):e13755. doi: 10.1371/journal.pone.0013755.
3
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.含佐剂的大流行性流感 H1N1 疫苗可在医护人员中提供早期和长期保护。
Vaccine. 2010 Dec 16;29(2):266-73. doi: 10.1016/j.vaccine.2010.10.038. Epub 2010 Oct 27.
4
A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.单剂未修饰的新型 2009 H1N1 疫苗在年轻和老年成年人中具有免疫原性和良好的耐受性。
J Infect Dis. 2010 Nov 1;202(9):1327-37. doi: 10.1086/656601.
5
Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009.2009 年甲型 H1N1 流感病毒在纽约市基于学校的暴发后的家庭传播,2009 年 4 月至 5 月。
J Infect Dis. 2010 Apr 1;201(7):984-92. doi: 10.1086/651145.
6
Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.3至17岁儿童对2009年甲型H1N1流感疫苗的反应。
N Engl J Med. 2010 Jan 28;362(4):370-2. doi: 10.1056/NEJMc0909988. Epub 2009 Dec 30.
7
Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.婴幼儿接种单价 2009 年甲型 H1N1 流感疫苗的免疫原性:一项随机试验。
JAMA. 2010 Jan 6;303(1):37-46. doi: 10.1001/jama.2009.1911. Epub 2009 Dec 21.
8
2009 influenza A(H1N1) monovalent vaccines for children.用于儿童的2009甲型H1N1流感单价疫苗
JAMA. 2010 Jan 6;303(1):73-4. doi: 10.1001/jama.2009.1929. Epub 2009 Dec 21.
9
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.中国 2009 年甲型 H1N1 流感疫苗的安全性和免疫原性:一项多中心、双盲、随机、安慰剂对照试验。
Lancet. 2010 Jan 2;375(9708):56-66. doi: 10.1016/S0140-6736(09)62003-1. Epub 2009 Dec 15.
10
Pandemic influenza A (H1N1) 2009 virus vaccine - conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts.2009年甲型H1N1大流行性流感病毒疫苗——免疫战略咨询专家组2009年10月会议的结论与建议
Wkly Epidemiol Rec. 2009 Dec 4;84(49):505-8.